Transcription factors in myeloid development: balancing differentiation with transformation
The DOI matches its Crossref record; 141 of the 142 references it cites were found in a registry or an index.
Abstract
In recent years, great progress has been made in elucidating the progenitor-cell hierarchy of the myeloid lineage. Transcription factors have been shown to be key determinants in the orchestration of myeloid identity and differentiation fates. Most transcription factors show cell-lineage-restricted and stage-restricted expression patterns, indicating the requirement for tight regulation of their activities. Moreover, if dysregulated or mutated, these transcription factors cause the differentiation block observed in many myeloid leukaemias. Consequently, therapies designed to restore defective transcription factor functions are an attractive option in the treatment of myeloid and other human cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, downregulation of PU.1 was identified as a mechanism for the induction of leukemias generated by PML-RARa, FLT3-ITD, and AML1-ETO.[43][44][45]”
From USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism (2018) · cites this paper as [43]
In the citing paper
“PU.1, a non-canonical pioneer transcription factor that functions as a master regulator of myeloid and lymphoid lineage differentiation18–20.”
From Lymphoid gene expression supports neuroprotective microglia function (2025) · cites this paper as [18]
In the citing paper
“Irf8 promotes GM lineage differentiation.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [29]
In the citing paper
“In particular, Irf8 promotes monocyte differentiation as a lineage switch between monocyte and granulocyte bifurcation29.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [29]
In the citing paper
“All activated macrophages, regardless of polarization state, express high levels of the transcription factors runt-related transcription factor 1 (RUNX1) and PU.1, which are thought to represent global regulators of macrophage phenotypic expression [20–22].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [20]
Citations
Cites
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617 · cited 1×
“The first lymphoid progenitor population that is known to arise from MPPs is the common lymphoid progenitors (CLPs; LIN − IL-7Rα + SCA1 low KIT low”
BackgroundIdentification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Differentiation and proliferation of hematopoietic stem cells
Ogawa, M. (1993) · Blood · doi:10.1182/blood.v81.11.2844.2844 · Cited by 1,383
Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential
Adolfsson, J., Månsson, R., Buza-Vidas, N., Hultquist, A., Liuba, K., Jensen, C. T., Bryder, D., Yang, L., Borge, O.-J., Thoren, L. A. M., et al. (2005) · Cell · doi:10.1016/j.cell.2005.02.013 · Cited by 1,236
Oncogenic Transcription Factors in the Human Acute Leukemias
Look, A. T. (1997) · Science · doi:10.1126/science.278.5340.1059 · Cited by 1,187
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells
Fogg, D. K., Sibon, C., Miled, C., Jung, S., Aucouturier, P., Littman, D. R., Cumano, A., & Geissmann, F. (2006) · Science · doi:10.1126/science.1117729 · Cited by 1,053
Research works printed but not linked: 1
- Iwasaki, H. et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106, 1590–1600 (2005). · DOI · Paper page
Cited by
Items 601–608 of 608
Finkbeiner, C., Otto, D. J., & Setty, M. N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.20.726634
Neutrophils in obesity: from expansion to dysfunction
Naranjo-Pinto, N., Alemán, O. R., & Rosales, C. (2026) · Clinical Immunology Communications · doi:10.1016/j.clicom.2026.05.005 · Cited by 1
Yang, J., Duan, X., Zhu, M., & Wu, Y. (2026) · Journal of Medical Genetics · doi:10.1136/jmg-2026-111543
Suzuki, K., Watanabe, N., Tsukune, Y., Inano, T., Kinoshita, S., Yamada, K., Ando, M., & Takaku, T. (2026) · Experimental Hematology · doi:10.1016/j.exphem.2026.105488
Tran, T. M., Lee, H. H., Hwang, T. H., Kim, M. H., Dang, N. M., Lee, M. G., Shim, J., Hwang, J. H., & Kim, J. Y. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1807068
“…reflect distinct biological states of the primary and immortalized cells, as actively proliferating progenitors have been reported to transiently suppress erythroid differentiation programs while maintaining self-renewal capacity (Rosenbauer and Tenen, 2007; Ruijtenberg and van den Heuvel, 2016).”
Ramani, M., Nguyen, N., Solis, J., Tenen, D. G., & Trinh, B. Q. (2026) · Biology · doi:10.3390/biology15181657
“Among the central regulators of hematopoiesis, PU.1, encoded by PU.1 (also called SPI1 ), occupies a uniquely important position because it governs both early cell-fate decisions and terminal effector functions across multiple immune lineages [1,4].”
Self-citationSHERLOCK: Structured representation learning and causal inference of downstream perturbation effectsPreprint
Zhang, M., Myers, J. D., Shi, L., Giglio, R. M., Chatterjee, S., McFaline‐Figueroa, J. L., & Azizi, E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.25.754573
REMANIEMENTS DU GENE NUP98 DANS LES HEMOPATHIES MALIGNES HUMAINES
Petit, A. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique)
Metadata
- Authors
- Rosenbauer, F., & Tenen, D. G.
- Affiliations
- Max Delbrück Center (DE)
- Harvard University (US)
- Venue
- Nature Reviews Immunology
- Published
- 2007-02
- Volume
- 7
- Issue
- 2
- Pages
- 105-117
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1980860344
- Cited by
- 606
- References
- 142
- Citations by year
- 2026: 20 · 2025: 20 · 2024: 21 · 2023: 24 · 2022: 29 · 2021: 17 · 2020: 21 · 2019: 28 · 2018: 30 · 2017: 45 · 2016: 31 · 2015: 42 · 2014: 38 · 2013: 43 · 2012: 27
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- Lymphoma Research Foundation
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- transcription factors, myeloid development, myeloid differentiation, myeloid leukemia, differentiation block, transcription factor dysregulation, cell fate regulation
- MeSH terms
- Animals, Cell Differentiation, Cell Transformation, Neoplastic, Hematopoietic Stem Cells, Humans, Leukemia, Myeloid, Transcription Factors, Mice, Knockout, Cell Lineage, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.